Jathin Bandari

Insider Reports History

Entity
Individual
Location
C/O Protora Therapeutics, Inc., 345 Park Avenue South, 3 Rd Floor, New York, NY
Signature
/s/ Mary Grendell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jathin Bandari:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Protara Therapeutics, Inc. Chief Medical Officer Common Stock 56.7K $108K $1.91 Jan 19, 2024 Direct
Protara Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 137K Jan 19, 2024 Direct

Insider Reports Filed by Jathin Bandari

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TARA Protara Therapeutics, Inc. Jan 19, 2024 3 -$5.5K 4 Jan 23, 2024 Chief Medical Officer
TARA Protara Therapeutics, Inc. Jan 10, 2024 1 -$4.49K 4 Jan 12, 2024 Chief Medical Officer
TARA Protara Therapeutics, Inc. Jul 3, 2023 1 -$1.68K 4 Jul 5, 2023 Chief Medical Officer
TARA Protara Therapeutics, Inc. Jan 19, 2023 2 $0 4 Jan 20, 2023 Chief Medical Officer
TARA Protara Therapeutics, Inc. Jan 10, 2023 1 -$5.63K 4 Jan 11, 2023 Chief Medical Officer
TARA Protara Therapeutics, Inc. Jul 1, 2022 1 -$2.2K 4 Jul 5, 2022 Chief Medical Officer
TARA Protara Therapeutics, Inc. Jan 10, 2022 0 $0 4/A Mar 9, 2022 Chief Medical Officer
TARA Protara Therapeutics, Inc. Jan 10, 2022 0 $0 3 Jan 12, 2022 Chief Medical Officer